Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regions

dc.contributor.authorGillies, Mark C
dc.contributor.authorArnold, Jennifer J
dc.contributor.authorBhandari, Sanjeeb
dc.contributor.authorEssex, Rohan
dc.contributor.authorYoung, Stephanie
dc.contributor.authorSquirrell, David
dc.contributor.authorNguyen, Vuong
dc.contributor.authorBarthelmes, Daniel
dc.date.accessioned2023-01-17T00:06:56Z
dc.date.issued2020
dc.date.updated2021-11-28T07:35:49Z
dc.description.abstractPurpose: To report and compare 10-year treatment outcomes of vascular endothelial growth factor (VEGF) inhibitors for neovascular age-related macular degeneration (nAMD) from Australia and New Zealand (ANZ) and Switzerland.en_AU
dc.description.sponsorshipMark Gillies has received research support from NHMRC, RANZCO Eye Foundation, Novartis, and Bayer. Jennifer Arnold is a member of the advisory boards for Allergan, Alcon, Bayer, and Novartis. Daniel Barthelmes has received research support from Novartis and Bayer. All other authors indicate no financial support or financial conflict of interest.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0002-9394en_AU
dc.identifier.urihttp://hdl.handle.net/1885/282806
dc.language.isoen_AUen_AU
dc.publisherElsevieren_AU
dc.rights© 2019 Elsevier Inc.en_AU
dc.sourceAmerican Journal of Ophthalmologyen_AU
dc.titleTen-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two Regionsen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.lastpage124en_AU
local.bibliographicCitation.startpage116en_AU
local.contributor.affiliationGillies, Mark C, University of Sydneyen_AU
local.contributor.affiliationArnold, Jennifer J, Marsden Eye Specialistsen_AU
local.contributor.affiliationBhandari, Sanjeeb, University of Sydneyen_AU
local.contributor.affiliationEssex, Rohan, College of Health and Medicine, ANUen_AU
local.contributor.affiliationYoung, Stephanie, Gladesville Eye Specialists,en_AU
local.contributor.affiliationSquirrell, David, University of Aucklanden_AU
local.contributor.affiliationNguyen, Vuong, University of Sydneyen_AU
local.contributor.affiliationBarthelmes, Daniel, University of Sydneyen_AU
local.contributor.authoruidEssex, Rohan, u5102645en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor000000 - Internal ANU use onlyen_AU
local.identifier.ariespublicationu6269649xPUB634en_AU
local.identifier.citationvolume210en_AU
local.identifier.doi10.1016/j.ajo.2019.10.007en_AU
local.identifier.scopusID2-s2.0-85075907251
local.publisher.urlhttps://www.elsevier.com/en-auen_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1-s2.0-S0002939419304969-main.pdf
Size:
1.43 MB
Format:
Adobe Portable Document Format
Description:
abcd